| # | Drug | Count |
|---|---|---|
| 0 | ALPRAZOLAM | 28 |
| 1 | DIAZEPAM | 26 |
| 2 | ASPIRIN | 24 |
| 3 | ASPIRIN 325 MG | 24 |
| 4 | ASPIRIN 81 MG | 24 |
| 5 | QUETIAPINE | 19 |
| 6 | DIAZEPAM ORAL | 18 |
| 7 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 18 |
| 8 | PREGABALIN | 18 |
| 9 | PREDNISONE | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | 1 | 0.0370 |
| 1 | AMPICILLIN SODIUM, SULBACTAM SODIUM | 1 | 0.0263 |
| 2 | BOTULISM ANTITOXIN HEPTAVALENT | 1 | 0.0078 |
| 3 | CARTEOLOL HYDROCHLORIDE | 2 | 0.0060 |
| 4 | HYALURONIC ACID | 6 | 0.0051 |
| 5 | SODIUM HYALURONATE | 4 | 0.0049 |
| 6 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 3 | 0.0025 |
| 7 | FLUMAZENIL | 2 | 0.0023 |
| 8 | TROPICAMIDE | 3 | 0.0018 |
| 9 | MITOMYCIN | 6 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 64 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 64 |
| 2 | Corticosteroid [EPC] | 47 |
| 3 | Atypical Antipsychotic [EPC] | 33 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 24 |
| 5 | Prostaglandin Analog [EPC] | 23 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 19 |
| 7 | Opioid Agonist [EPC] | 16 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 16 |
| 9 | Mood Stabilizer [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Benzodiazepine Antagonist [EPC] | 2 | 0.0023 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 3 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 4 | Anticholinergic [EPC] | 12 | 0.0007 |
| 5 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 6 | Plasma Volume Expander [EPC] | 2 | 0.0006 |
| 7 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 1 | 0.0006 |
| 8 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 9 | Ectoparasiticide [EPC] | 2 | 0.0005 |